Zhou P - Search Results

1

Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.

Hao J, Fan W, Li Y, Tang R, Tian C, Yang Q, Zhu T, Diao C, Hu S, Chen M, Guo P, Long Q, Zhang C, Qin G, Yu W, Chen M, Li L, Qin L, Wang J, Zhang X, Ren Y, Zhou P, Zou L, Jiang K, Guo W, Deng W. Hao J, et al. Among authors: zhou p. J Exp Clin Cancer Res. 2019 Feb 4;38(1):48. doi: 10.1186/s13046-019-1036-z. J Exp Clin Cancer Res. 2019. PMID: 30717768 Free PMC article.

2

DGKA Mediates Resistance to PD-1 Blockade.

Fu L, Li S, Xiao W, Yu K, Li S, Yuan S, Shen J, Dong X, Fang Z, Zhang J, Chen S, Li W, You H, Xia X, Kang T, Tan J, Chen G, Yang AK, Gao Y, Zhou P. Fu L, et al. Among authors: zhou p. Cancer Immunol Res. 2021 Apr;9(4):371-385. doi: 10.1158/2326-6066.CIR-20-0216. Epub 2021 Feb 19. Cancer Immunol Res. 2021. PMID: 33608256

3

Mevalonate Blockade in Cancer Cells Triggers CLEC9A⁺ Dendritic Cell-Mediated Antitumor Immunity.

Xu F, Wang Z, Zhang H, Chen J, Wang X, Cui L, Xie C, Li M, Wang F, Zhou P, Liu J, Huang P, Xia X, Xia X. Xu F, et al. Among authors: zhou p. Cancer Res. 2021 Sep 1;81(17):4514-4528. doi: 10.1158/0008-5472.CAN-20-3977. Epub 2021 Jul 15. Cancer Res. 2021. PMID: 34266895

4

Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity.

Zhang X, Cheng L, Gao C, Chen J, Liao S, Zheng Y, Xu L, He J, Wang D, Fang Z, Zhang J, Yan M, Luan Y, Chen S, Chen L, Xia X, Deng C, Chen G, Li W, Liu Z, Zhou P. Zhang X, et al. Among authors: zhou p. Cancer Res. 2023 Mar 15;83(6):906-921. doi: 10.1158/0008-5472.CAN-22-2405. Cancer Res. 2023. PMID: 36634207

5

Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.

Hao J, Fan W, Li Y, Tang R, Tian C, Yang Q, Zhu T, Diao C, Hu S, Chen M, Guo P, Long Q, Zhang C, Qin G, Yu W, Chen M, Li L, Qin L, Wang J, Zhang X, Ren Y, Zhou P, Zou L, Jiang K, Guo W, Deng W. Hao J, et al. Among authors: zhou p. J Exp Clin Cancer Res. 2024 Jun 26;43(1):178. doi: 10.1186/s13046-024-03104-w. J Exp Clin Cancer Res. 2024. PMID: 38926774 Free PMC article. No abstract available.

6

cGAS/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity.

Wang Z, Chen J, Hu J, Zhang H, Xu F, He W, Wang X, Li M, Lu W, Zeng G, Zhou P, Huang P, Chen S, Li W, Xia LP, Xia X. Wang Z, et al. Among authors: zhou p. J Clin Invest. 2019 Aug 13;129(11):4850-4862. doi: 10.1172/JCI127471. J Clin Invest. 2019. PMID: 31408442 Free PMC article.

7

A Feedback Circuitry between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal Tumorigenesis.

Liao K, Deng S, Xu L, Pan W, Yang S, Zheng F, Wu X, Hu H, Liu Z, Luo J, Zhang R, Kuang DM, Dong J, Wu Y, Zhang H, Zhou P, Bei JX, Xu Y, Ji Y, Wang P, Ju HQ, Xu RH, Li B. Liao K, et al. Among authors: zhou p. Cancer Res. 2020 Feb 15;80(4):675-688. doi: 10.1158/0008-5472.CAN-19-2060. Epub 2020 Jan 16. Cancer Res. 2020. PMID: 31948940

8

Chimeric antigen receptor-modified T-cell therapy for platelet-derived growth factor receptor α-positive rhabdomyosarcoma.

Xiao W, Wang J, Wen X, Xu B, Que Y, Yu K, Xu L, Zhao J, Pan Q, Zhou P, Zhang X. Xiao W, et al. Among authors: zhou p. Cancer. 2020 May 1;126 Suppl 9:2093-2100. doi: 10.1002/cncr.32764. Cancer. 2020. PMID: 32293729 Free article.

9

Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma.

Que Y, Zhang XL, Liu ZX, Zhao JJ, Pan QZ, Wen XZ, Xiao W, Xu BS, Hong DC, Guo TH, Shen LJ, Fan WJ, Chen HY, Weng DS, Xu HR, Zhou PH, Zhang YZ, Niu XH, Zhang X. Que Y, et al. J Immunother Cancer. 2021 Feb;9(2):e001696. doi: 10.1136/jitc-2020-001696. J Immunother Cancer. 2021. PMID: 33637599 Free PMC article.

10

Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer.

Sui Q, Liu D, Jiang W, Tang J, Kong L, Han K, Liao L, Li Y, Ou Q, Xiao B, Liu G, Ling Y, Chen J, Liu Z, Zuo Z, Pan Z, Zhou P, Zheng J, Ding PR. Sui Q, et al. Among authors: zhou p. J Immunother Cancer. 2021 Mar;9(3):e001498. doi: 10.1136/jitc-2020-001498. J Immunother Cancer. 2021. PMID: 33782107 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,648 results

Search Page

Filters